Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Genesis Healthcare (GEN) Competitors

Genesis Healthcare logo

GEN vs. CDAY, CCCS, ZI, SVFCX, SEMR, MIXT, XPER, IDN, MAQC, and MTBLY

Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Ceridian HCM (CDAY), CCC Intelligent Solutions (CCCS), ZoomInfo Technologies (ZI), Smead Value C (SVFCX), Semrush (SEMR), MiX Telematics (MIXT), Xperi (XPER), Intellicheck (IDN), Maquia Capital Acquisition (MAQC), and Moatable (MTBLY).

Genesis Healthcare vs. Its Competitors

Genesis Healthcare (NYSE:GEN) and Ceridian HCM (NYSE:CDAY) are both large-cap prepackaged software industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

82.1% of Genesis Healthcare shares are held by institutional investors. 3.3% of Genesis Healthcare shares are held by company insiders. Comparatively, 4.5% of Ceridian HCM shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Genesis Healthcare has a net margin of 17.83% compared to Ceridian HCM's net margin of 0.28%. Genesis Healthcare's return on equity of 155.48% beat Ceridian HCM's return on equity.

Company Net Margins Return on Equity Return on Assets
Genesis Healthcare17.83% 155.48% 9.12%
Ceridian HCM 0.28%2.03%0.51%

Genesis Healthcare presently has a consensus target price of $33.25, suggesting a potential upside of 22.97%. Given Genesis Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Genesis Healthcare is more favorable than Ceridian HCM.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genesis Healthcare
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Ceridian HCM
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Genesis Healthcare has higher revenue and earnings than Ceridian HCM. Genesis Healthcare is trading at a lower price-to-earnings ratio than Ceridian HCM, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genesis Healthcare$2.80B6.18$836M$0.9030.04
Ceridian HCM$1.45B7.38-$73.40M$0.032,284.00

In the previous week, Genesis Healthcare's average media sentiment score of 0.00 equaled Ceridian HCM'saverage media sentiment score.

Company Overall Sentiment
Genesis Healthcare Neutral
Ceridian HCM Neutral

Genesis Healthcare has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Ceridian HCM has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.

Summary

Genesis Healthcare beats Ceridian HCM on 10 of the 14 factors compared between the two stocks.

Get Genesis Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEN vs. The Competition

MetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE Exchange
Market Cap$17.28B$9.84B$94.72T$21.35B
Dividend Yield3.05%0.89%2.85%3.58%
P/E Ratio30.04168.4725.9428.87
Price / Sales6.184.0374,762.3191.96
Price / Cash8.4261.2431.0824.53
Price / Book-169.004.05185,976.794.51
Net Income$836M$81.91M$196.66M$1.01B

Genesis Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEN
Genesis Healthcare
2.3121 of 5 stars
$27.04
-0.7%
$33.25
+23.0%
-1.3%$17.28B$2.80B30.042,700
CDAY
Ceridian HCM
N/A$68.96
0.0%
N/A+13.4%$10.77B$1.45B2,299.438,526
CCCS
CCC Intelligent Solutions
3.5229 of 5 stars
$9.49
+1.2%
$11.75
+23.8%
-13.7%$6.18B$996.96M474.742,350Positive News
ZI
ZoomInfo Technologies
0.7501 of 5 stars
$10.43
-0.2%
$11.18
+7.3%
+4.9%$3.57B$1.21B347.623,540Positive News
SVFCX
Smead Value C
N/A$80.31
+0.9%
N/AN/A$3.30BN/A0.002
SEMR
Semrush
4.0278 of 5 stars
$7.42
+0.9%
$13.50
+82.0%
-43.8%$1.10B$413.96M92.741,170News Coverage
High Trading Volume
MIXT
MiX Telematics
N/A$14.55
flat
N/AN/A$353.75M$150.06M58.201,080
XPER
Xperi
2.6906 of 5 stars
$6.87
+0.1%
$13.50
+96.6%
-21.5%$317.71M$475.22M-3.612,100
IDN
Intellicheck
2.2087 of 5 stars
$4.98
-4.8%
$6.17
+23.8%
+142.4%$99.78M$20.66M-166.0050
MAQC
Maquia Capital Acquisition
N/A$11.30
flat
N/AN/A$58.99MN/A0.004
MTBLY
Moatable
1.2563 of 5 stars
$2.93
-0.7%
N/A+254.9%$53.12M$52.07M-29.30410News Coverage
Gap Down

Related Companies and Tools


This page (NYSE:GEN) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners